Combined Hormonal Contraceptives Market: Growth & Revenue Opportunities by Top Key Players Actavis Plc., Agile Therapeutics, Inc., Allergan Plc., Bayer AG, Teva Pharmaceutical Industries Ltd. and more

Combined hormonal contraceptives are used to prevent pregnancy. They are also used to treat irregular menstruation, preventing acne vulgaris, endometriosis, polycystic ovary syndrome and ovulation. These products are widely used by women between 15 and 49 years old.

Factors that drive the combined hormone contraceptive market include increased combined hormonal contraception and contraception in developing countries and the development of polycystic ovary syndrome (PCOS). In addition, the growth of higher education populations, the need for family planning, and the growth of measures to prevent unwanted pregnancies further accelerate market growth.

However, health risks associated with contraceptive use and people's lack of social acceptance limit the market. The growing awareness of contraceptives among people and initiatives taken by governments in undeveloped emerging economies offers significant opportunities for market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2935?utm_source=sy

Key players profiled in the report include
• Actavis Plc.
• Agile Therapeutics Inc.
• Allergan Plc.
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• ANI Pharmaceuticals Inc.
• Ortho-McNeil-Janssen Pharmaceuticals Inc.
• Noven Pharmaceuticals Inc.
• Johnson & Johnson
• Mylan Inc.

Combined hormonal contraceptives market is segmented on the basis of product type, age group, end users, and region. Based on product type, the market is bifurcated into drugs (combined oral contraceptive pills, combined injectable birth control, and combined emergency contraceptive pills) and devices (combined vaginal rings, and combined transdermal patches).

On the basis of age group the market is categorized into 1524, 2534, 3544, and above 44 years. By end user, the market is classified into hospitals, household, and clinics. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2935?utm_source=sy

Key Benefits
• The study provides an in-depth analysis of the global combined hormonal contraceptives market with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides information about the current and upcoming trends in the global combined hormonal contraceptives market from 2016 to 2023, which helps to determine the prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the geriatric care devices market is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the combined hormonal contraceptives.

Access Full Summery @ https://www.alliedmarketresearch.com/combined-hormonal-contraceptives-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.